These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 209591)

  • 1. Serum albumin and total globulin levels in common liver diseases in Accra (Ghana).
    Fenuku RI; Foli AK
    Trop Geogr Med; 1978 Mar; 30(1):87-90. PubMed ID: 209591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of serum basic fibroblast growth factor levels in chronic liver diseases and hepatocellular carcinoma.
    Hsu PI; Chow NH; Lai KH; Yang HB; Chan SH; Lin XZ; Cheng JS; Huang JS; Ger LP; Huang SM; Yen MY; Yang YF
    Anticancer Res; 1997; 17(4A):2803-9. PubMed ID: 9252719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
    Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
    Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum globulin subfraction variations in liver cirrhosis and hepatoma.
    Kageyama T; Kimoto S; Toda H; Oyabu H; Watanabe I
    Bull Osaka Med Sch; 1975 Oct; 21(2):132-9. PubMed ID: 181107
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum proteins in hepatic disease.
    Teloh HA
    Ann Clin Lab Sci; 1978; 8(2):127-9. PubMed ID: 637517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte 2,3-diphosphoglycerate in liver diseases.
    Nakano T; Fujioka H; Tamura S; Amuro Y; Nabeshima K; Hada T; Higashino K
    Am J Gastroenterol; 1987 Dec; 82(12):1283-6. PubMed ID: 2825516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases.
    Lin CC; Huang JF; Tsai LY; Huang YL
    Biol Trace Elem Res; 2006 Jan; 109(1):15-24. PubMed ID: 16388099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
    Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
    Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
    [No Abstract]   [Full Text] [Related]  

  • 11. Thyroxine-binding globulin in patients with chronic hepatitis B virus infection: different implications in hepatitis and hepatocellular carcinoma.
    Huang MJ; Liaw YF
    Am J Gastroenterol; 1990 Mar; 85(3):281-4. PubMed ID: 1689951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum calcitonin levels in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Sagara K; Sato T
    Horm Metab Res; 1986 Jun; 18(6):421-2. PubMed ID: 3015758
    [No Abstract]   [Full Text] [Related]  

  • 13. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
    Uehara M; Sato N
    Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminant analysis of biochemical parameters in liver disease.
    Olubuyide IO; Festing MF; Chapman C; Higginson J; Whicher JT
    Trop Gastroenterol; 1997; 18(1):15-9. PubMed ID: 9197166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The level of IL-8 in the serum of patients suffering from chronic hepatic diseases and primary hepatocellular carcinoma].
    Tong L; Zhu L; Fan Y; Lu B
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):432-3. PubMed ID: 12502445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
    Hioki O; Watanabe A; Minemura M; Tsuchida T
    J Med; 1993; 24(1):35-46. PubMed ID: 7684768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver immunoreactive prolyl hydroxylase protein in human primary hepatocellular carcinoma.
    Bolarin D; Andy JJ; Alabi ZO
    Hepatogastroenterology; 1983 Dec; 30(6):230-2. PubMed ID: 6327476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.